REPORTING OF ASSIGNMENT METHODS IN CLINICAL-TRIALS

被引:21
|
作者
WILLIAMS, DH
DAVIS, CE
机构
[1] Department of Biostatistics, University of North Carolina, Chapel Hill, NC
来源
CONTROLLED CLINICAL TRIALS | 1994年 / 15卷 / 04期
关键词
RANDOMIZATION; ASSIGNMENT METHODS; CLINICAL TRIALS;
D O I
10.1016/0197-2456(94)90045-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
A stratified random sample of the reports of 200 clinical trials, conducted in the 1980s, listed in the February 1991 issue of Controlled Clinical Trials, was reviewed. The four strata were small single-center trials (SST), small multicenter trials (SMT), large single-center trials (LST), and large multicenter trials (LMT). The description of the assignment method in the published reports of the results of the trials was classified into four categories: good description (G), provides details; fair description (F), describes some details; poor description (P), only states that randomization was used; and no description (N). The percentage of good and fair descriptions among the four strata were: (Graphics) The proportion of G or F trials is slightly higher in the LST because one third used systematic rather than random assignment, which is easier to describe. Good descriptions usually require only two or three lines of text, and yet the description of the randomization method for most clinical trials is so poor that the reader cannot tell if randomization has been applied properly.
引用
收藏
页码:294 / 298
页数:5
相关论文
共 50 条
  • [31] REVIEW OF CLINICAL-TRIALS - PROVING THE LIPID HYPOTHESIS
    BROWN, WV
    EUROPEAN HEART JOURNAL, 1990, 11 : 15 - 20
  • [32] COMPARATIVE TOLERABILITY PROFILE OF OMEPRAZOLE IN CLINICAL-TRIALS
    SIMON, TJ
    BRADSTREET, DC
    DIGESTIVE DISEASES AND SCIENCES, 1991, 36 (10) : 1384 - 1389
  • [33] NEGATIVE SYMPTOMS IN SCHIZOPHRENIA - CONSIDERATIONS FOR CLINICAL-TRIALS
    MOLLER, HJ
    VANPRAAG, HM
    AUFDEMBRINKE, B
    BAILEY, P
    BARNES, TRE
    BECK, J
    BENTSEN, H
    EICH, FX
    FARROW, L
    FLEISCHHACKER, WW
    GERLACH, J
    GRAFFORD, K
    HENTSCHEL, B
    HERTKORN, A
    HEYLEN, S
    LECRUBIER, Y
    LEONARD, JP
    MCKENNA, P
    MAIER, W
    PEDERSEN, V
    RAPPARD, A
    REIN, W
    RYAN, J
    NIELSEN, MS
    STIEGLITZ, RD
    WEGENER, G
    WILSON, J
    PSYCHOPHARMACOLOGY, 1994, 115 (1-2) : 221 - 228
  • [34] THE EPIDEMIOLOGIC AND ECONOMIC CONSEQUENCES OF AIDS CLINICAL-TRIALS
    PALTIEL, AD
    KAPLAN, EH
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (02): : 179 - 190
  • [35] PHASE-I CLINICAL-TRIALS IN DERMATOLOGY
    CZERNIELEWSKI, J
    QUEILIEROUSSEL, C
    DUTEIL, L
    VERSCHOORE, M
    SCHAEFER, H
    REVUZ, J
    DEPROST, Y
    GUILLAUME, JC
    ORTONNE, JP
    THERAPIE, 1991, 46 (03): : 183 - 187
  • [36] SEPSIS AND CONTROLLED CLINICAL-TRIALS - THE ODYSSEY CONTINUES
    BONE, RC
    CRITICAL CARE MEDICINE, 1995, 23 (08) : 1313 - 1315
  • [37] ON THE DESIGN OF CLINICAL-TRIALS FOR TREATMENT OF OPIATE DEPENDENCE
    JAIN, RB
    COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 1994, 23 (02) : 589 - 613
  • [38] RANDOMIZED CLINICAL-TRIALS IN ONCOLOGY - PRINCIPLES AND OBSTACLES
    SIMON, R
    CANCER, 1994, 74 (09) : 2614 - 2619
  • [39] DESIGN AND ANALYTIC CONCEPTS FOR PERIODONTAL CLINICAL-TRIALS
    IMREY, PB
    CHILTON, NW
    JOURNAL OF PERIODONTOLOGY, 1992, 63 (12) : 1124 - 1140
  • [40] SOME TOPICS OF CURRENT INTEREST IN CLINICAL-TRIALS
    ARMITAGE, P
    CANADIAN JOURNAL OF STATISTICS-REVUE CANADIENNE DE STATISTIQUE, 1992, 20 (01): : 1 - 8